BASAGLAR
BASAGLAR
Approved
DIN Number
02461528
Drug Class
Human
Market Date
Aug 18, 2017
Company
HC
eli lilly canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02461528
AIG Number0147062001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE04 INSULIN GLARGINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN GLARGINEActive
Strength: 100 UNIT / ML
Monograph: INSULIN GLARGINE